Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1996
12/19/1996CA2223033A1 High affinity human monoclonal antibodies specific for rsv f-protein
12/19/1996CA2222999A1 Novel ctla4/cd28 ligands and uses therefor
12/19/1996CA2222972A1 Reversible cysteine protease inhibitors
12/19/1996CA2222947A1 Inhibin compositions and methods of enhancing production performance
12/19/1996CA2222793A1 Optimized minizymes and miniribozymes and uses thereof
12/19/1996CA2222789A1 Bone stimulating factor
12/19/1996CA2222690A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
12/19/1996CA2222538A1 Apparatus and method for delivering a biologically active compound into a biological environment
12/19/1996CA2222520A1 Oligonucleotides specific for cytokine signal transducer gp130 mrna
12/19/1996CA2222239A1 A method of crosslinking amino acid-containing polymers using photoactivatable chemical cross-linkers
12/19/1996CA2222231A1 Antibody and antibody fragments for inhibiting the growth of tumors
12/19/1996CA2222183A1 Stable reagents for the preparation of radiopharmaceuticals
12/19/1996CA2222162A1 Pericardial therapeutic and diagnostic agent delivery
12/19/1996CA2222135A1 Hapten modified tumor cell extract and methods of treating or screening for cancer
12/19/1996CA2222066A1 Hemodilution facilitated by monitoring oxygenation status
12/19/1996CA2221821A1 Endothelial-monocyte activating polypeptide iii
12/19/1996CA2221780A1 Anti-fungal d-amino acid histatin-based peptides
12/19/1996CA2221710A1 Gene therapy for myocardial ischemia
12/19/1996CA2221690A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996CA2221646A1 Synthetic peptides and pharmaceutical compositions comprising them
12/19/1996CA2221602A1 Essential oligonucleotides of vertebrate telomerase
12/19/1996CA2221601A1 Regulation of cytokine synthesis and release
12/19/1996CA2221570A1 Neutralizing conformation epitopes of chicken anemia virus
12/19/1996CA2221480A1 Mutants of streptococcal toxin a and methods of use
12/19/1996CA2221146A1 Structurally determined metallo-constructs and applications
12/19/1996CA2220957A1 Glycine and phaseolus .alpha.-d-galactosidases
12/19/1996CA2220952A1 Anti-allergy bispecific molecules
12/19/1996CA2220714A1 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
12/19/1996CA2219980A1 Method for inhibiting neoplastic disease in mammals
12/19/1996CA2219457A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation
12/19/1996CA2219242A1 Modified hemoglobin-like compounds and methods of purifying same
12/19/1996CA2197244A1 Wound healing formulations containing human plasma fibronectin
12/19/1996CA2196691A1 Macrophage derived chemokine and chemokine analogs
12/19/1996CA2196334A1 Urokinase receptor ligands
12/18/1996EP0748870A2 Oncostatin M induced hematopoiesis
12/18/1996EP0748817A2 Parathyroid hormone derivatives and their use
12/18/1996EP0748816A1 Toxoplasma gondii antigen, its production and use
12/18/1996EP0748815A1 Toxoplasma gondii antigen, its production and use
12/18/1996EP0748633A2 Adhesive tissue and its use as haemostyptic
12/18/1996EP0748631A2 Viral vaccines
12/18/1996EP0748630A1 Urinastatin-containing suppository
12/18/1996EP0748591A1 Fluorinated micellar casein
12/18/1996EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
12/18/1996EP0748384A1 Transgenic plants for the control of animal parasites
12/18/1996EP0748383A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
12/18/1996EP0748380A1 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID $g(b)-PROTEIN PRECURSOR INHIBITOR
12/18/1996EP0748377A1 IMPROVED DNase LIQUID SOLUTIONS
12/18/1996EP0748376A1 Rna editing enzyme and methods of use thereof
12/18/1996EP0748374A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
12/18/1996EP0748338A1 In vitro antibody affinity maturation using alanine scanning mutagenesis
12/18/1996EP0748337A1 Process for the obtention of a biological adhesive comprising fibrinogen, factor xiii and fibronectin
12/18/1996EP0748336A1 Immunosuppressive compounds and method of preparing same
12/18/1996EP0748335A1 Antibiotic stalobacins
12/18/1996EP0748333A1 Antithrombotic agents
12/18/1996EP0748226A1 Block copolymers
12/18/1996EP0748225A1 PHARMACEUTICALLY ACCEPTABLE DNase FORMULATION
12/18/1996EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
12/18/1996EP0748217A1 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
12/18/1996EP0748215A1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
12/18/1996EP0748213A1 Methods and compositions for pulmonary delivery of insulin
12/18/1996EP0748191A1 Methods and formulations for use in treating oophorectomized women
12/18/1996EP0748190A1 Methods and formulations for use in treating benign gynecological disorders
12/18/1996EP0695171B1 Lyospheres comprising gonadotropin
12/18/1996EP0662147B1 Small cell lung carcinoma specific antibody and antigen
12/18/1996EP0621774B1 Improved process for preparing micronized polypeptide drugs
12/18/1996EP0618802A4 Synthetic compounds and compositions with enhanced cell binding.
12/18/1996EP0609242B1 New thrombin-inhibiting protein isolated from ticks
12/18/1996EP0555479B1 Epoxysuccinamic acid derivative
12/18/1996EP0554284B1 Peptide-based inhibitors of hiv replication
12/18/1996EP0526608B1 Therapeutic agents for the treatment of multidrug resistance to cancers
12/18/1996CN1138350A CNTF Family antagonists
12/18/1996CN1138349A Human activated protein C preparation and process for producing the same
12/18/1996CN1138335A Compounds with growth hormone releasing properties
12/18/1996CN1138334A Compounds with growth hormone releasing properties
12/18/1996CN1138297A Method of stabilizing protein C or activated protein C and stabilized composition
12/18/1996CN1138295A A novel tumor suppressor gene
12/18/1996CN1033584C Benzo-fused lactams that promote release of growth hormone
12/17/1996US5585499 Drug delivery
12/17/1996US5585486 Peptidic ketones as interleukin-1β-converting enzyme inhibitors
12/17/1996US5585484 Using ethoxylated phenylmaleimido compounds
12/17/1996US5585479 Useful for the treatment of septic shock and inflammatory complications of shock
12/17/1996US5585478 D4 gene and methods of use thereof
12/17/1996US5585475 Does not exhibit strict alpha-helical conformations
12/17/1996US5585474 DNA encoding protein possessing metastasis-inhibitory activity
12/17/1996US5585467 Cultivating a mycins from fungus strain
12/17/1996US5585464 Recombinant antigen for diagnosing rheumatoid arthritis
12/17/1996US5585463 β3 integrin subunit specific polypeptides, cDNAs which encode these polypeptides and method of producing these polypeptides
12/17/1996US5585461 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
12/17/1996US5585397 Viricides
12/17/1996US5585376 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
12/17/1996US5585362 Adenovirus vectors for gene therapy
12/17/1996US5585361 Intravenous administration of hyaluronic acid or its salts
12/17/1996US5585360 Thrombin inhibitors
12/17/1996US5585359 Inhibitors of farnesyl-protein transferase
12/17/1996US5585357 Heteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitors
12/17/1996US5585356 Matrix metalloproteinase peptides: role in diagnosis and therapy
12/17/1996US5585355 Drug delivery with a bradykinin derivatives
12/17/1996US5585354 Suppressant of corneal subepithelial clouding
12/17/1996US5585353 Antibiotic peptides containing D-amino acids
12/17/1996US5585352 Method of treating septic shock using thymosin-α 1